Research ExplorerScientific StaffMartin Lambert Publications

Prof. Dr. med. ID: 57412

Martin Lambert

Group leader

graph of relations
Affiliations
Emails
Phone: 0049-40-7410-24041Fax: 0049-40-7410-52999
351 - 400 out of 496Page size: 50

Publications

  1. 2006

  2. Treated incidence of first-episode psychosis in the catchment area of EPPIC between 1997 and 2000.

    Amminger, G. P., Harris, M. G., Conus, P., Lambert, M., Elkins, K. S., Yuen, H-P. & McGorry, P. D., 2006, In: ACTA PSYCHIAT SCAND. 114, 5, p. 337-345 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Umfassende Therapien psychotischer Störungen.

    Lambert, M. & Naber, D., 2006, In: Psychoneuro. 32(7+8), p. 300-402

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  4. 2005

  5. Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study.

    Lambert, M., Conus, P., Schimmelmann, B. G., Eide, P., Ward, J., Yuen, H., Schacht, M., Edwards, J., Naber, D. & McGorry, P. D., 2005, In: PHARMACOPSYCHIATRY. 38, 5, p. 206-213 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics.

    Schimmelmann, B. G., Moritz, S., Karow, A., Schafer, I., Bussopulos, A., Golks, D., Krausz, M., Naber, D. & Lambert, M., 2005, In: INT J PSYCHIAT CLIN. 9, p. 94-98

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Diagnose, Differentialdiagnose und Verlauf der Schizophrenie.

    Lambert, M., 2005, Schizophrenie und Bildgebung.. Braus, B. (ed.). Schattauer, p. 3-14

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  8. Diagnostic stability 18 months after treatment initiation for first-episode psychosis.

    Schimmelmann, B. G., Conus, P., Edwards, J., McGorry, P. D. & Lambert, M., 2005, In: J CLIN PSYCHIAT. 66, 10, p. 1239-1246 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Die Lebensqualität schizophrener Patienten unter besonderer Berücksichtigung von Quetiapin.

    Lambert, M., Karow, A. & Naber, D., 2005, Das Quetiapin-Dossier: Pharmakologie, Indikationen, therapeutische Erfahrungen.. Möller, H. J. (ed.). Schattauer, p. 245-261

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  10. Langzeitverlauf der Schizophrenie.

    Schäfer, I. & Lambert, M., 2005, Langzeittherapie der Schizophrenie.. Pajong, F. & Falkai, P. (eds.). Uni-Med, p. 40-45

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  11. Olanzapine in patients with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone.

    Lambert, M., Conus, P., Schimmelmann, B., Naber, D. & McGorry, P. D., 2005, In: INT J PSYCHIAT CLIN. 9, p. 244-250

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone

    Lambert, M., Conus, P., Naber, D., Mcgorry, P. D. & Schimmelmann, B. G., 2005, In: INT J PSYCHIAT CLIN. 9, 4, p. 244-50 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.

    Lambert, M., Haro, J. M., Novick, D., Edgell, E. T., Kennedy, L., Ratcliffe, M. & Naber, D., 2005, In: ACTA PSYCHIAT SCAND. 111, 3, p. 232-243 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. PANSS syndromes and quality of life in schizophrenia.

    Karow, A., Moritz, S., Lambert, M., Schoder, S. & Krausz, M., 2005, In: PSYCHOPATHOLOGY. 38, 6, p. 320-326 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.

    Gasquet, I., Haro, J. M., Novick, D., Edgell, E. T., Kennedy, L., Lepine, J. P. & SOHO Study Group, 2005, In: INT CLIN PSYCHOPHARM. 20, p. 199-205

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Pharmacological treatments of first-episode psychosis.

    Lambert, M., Conus, P., Lambert, T. J. & McGorry, P. D., 2005, In: Psychiatrie Sciences Humaines Neurosciences . 3, p. 80-92

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Psychiatry in Europe.

    Agius, M., Zaman, R., Singh, S., Gallagher, O., Jones, P. B., McGuire, P., Power, P., Craig, T., Bahn, S., Grech, A., Casha, C., Pace, C., Cassar, D., Blinc-Pesek, M., Avgustin, B., Gruber, E., Biocina, S. M., Andelic, J., Dinolova, R., van Os, J. & Lambert, M., 2005, In: BRIT J PSYCHIAT. 187, p. 92

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Psychopharmakotherapie der Schizophrenie.

    Fleischhacker, W. W., Naber, D. & Lambert, M., 2005, Therapie psychischer Erkrankungen: State of the Art. Vorderholzer, U. & Hohagen, F. (eds.). Urban & Fischer, p. 49-73

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  19. Psychopharmakotherapie der Schizophrenie.

    Lambert, M., 2005, Schizophrenie und Bildgebung. Braus, B. (ed.). Schattauer, p. 41-72

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  20. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.

    Naber, D., Riedel, M., Klimke, A., Vorbach, E-U., Lambert, M., Kühn, K-U., Bender, S., Bandelow, B., Lemmer, W., Moritz, S. & Dittmann, R. W., 2005, In: ACTA PSYCHIAT SCAND. 111, 2, p. 106-115 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders.

    McGorry, P. D., Killackey, E., Lambert, T. & Lambert, M., 2005, In: AUST NZ J PSYCHIAT. 39(1-2), p. 1-30

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics.

    Schimmelmann, B. G., Paulus, S., Schacht, M., Tilgner, C., Schulte-Markwort, M. & Lambert, M., 2005, In: J CHILD ADOL PSYCHOP. 15, 2, p. 249-258 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Subjective well-being under the neuroleptic treatment and its relevance for compliance.

    Naber, D., Karow, A. & Lambert, M., 2005, In: Acta Psychiatr Scand Suppl. 427, p. 29-34

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Symptomatik und Subtypisierung der Schizophrenie.

    Lambert, M., 2005, Schizophrenie und Bildgebung.. Braus, B. (ed.). Schattauer, p. 35-40

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  25. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.

    Lambert, M., Conus, P., Lubman, D. I., Wade, D., Yuen, H., Moritz, S., Naber, D., McGorry, P. D. & Schimmelmann, B. G., 2005, In: ACTA PSYCHIAT SCAND. 112, 2, p. 141-148 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. 2004

  27. Subjektive Befindlichkeit unter neuroleptischer Behandlung und ihre Bedeutung für Compliance und Krankheitsverlauf

    Naber, D., Lambert, M. & Karow, A., 11.2004, In: PSYCHIAT PRAX. 31 Suppl 2, p. S230-2

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Atypische Antipsychotika bei therapieresistenter Schizophrenie

    Schäfer, I., Lambert, M. & Naber, D., 01.2004, In: NERVENARZT. 75, 1, p. 79-91 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Die initial dysphorische Reaktion (IDR) auf die Ersteinnahme von Neuroleptika

    Schimmelmann, B. G., Schacht, M., Perro, C. & Lambert, M., 01.2004, In: NERVENARZT. 75, 1, p. 36-43 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.

    Naber, D. & Lambert, M., 2004, In: PROG NEURO-PSYCHOPH. 28, 8, p. 1213-1219 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. [Atypical antipsychotics in therapy refractory schizophrenia]

    Schäfer, I., Lambert, M. & Naber, D., 2004, In: NERVENARZT. 75, 1, p. 79-91 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.

    Lambert, M. & Naber, D., 2004, In: CNS DRUGS. 18, 2, p. 3-5 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Current schizophrenia.

    Lambert, M. & Naber, D., 2004, Science Press. 102 p.

    Research output: Book/anthology › Monographs › Research › peer-review

  34. Das Antipsychotikum Aripiprazol - Wirksamkeit und Verträglichkeit.

    Lambert, M., 2004, In: Die Psychiatrie. 1, p. 67-84

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  35. Discover the road ahead: Support and Guidance for Everyone Affected by Schizophrenia.

    Elgie, R., Van Amerongen, A., Byrne, P., D'Arienzo, S., Haley, C., Lambert, M., McGrae, J. & Sappia, S., 2004, Cambridge University Press Ltd.

    Research output: Book/anthology › Collected edition/anthology › Research

  36. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

    Lambert, M., Conus, P., Eide, P., Mass, R., Karow, A., Moritz, S., Golks, D. & Naber, D., 2004, In: EUR PSYCHIAT. 19, 7, p. 415-422 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Lebensqualität psychisch Kranker aus der Sicht der Betroffenen.

    Lambert, M., 2004, In: APK-Zeitschrift. 3, p. 16-17

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  38. Lehrbuch der Schizophrenie.

    Naber, D. & Lambert, M., 2004, Georg Thieme Verlag KG. 234 p.

    Research output: Book/anthology › Collected edition/anthology › Education

  39. Neurocognition under conventional and atypical neuroleptics - a critical review.

    Moritz, S., Lambert, M. & Naber, D., 2004, Kognition und Schizophrenie - Biopsychosoziale Konzepte. Lasar, M. & Goldbeck, F. (eds.). Lengerich: Pabst, p. 67-94

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  40. Patients' subjective well-being and quality of life in schizophrenia.

    Lambert, M., 2004, In: European GAMIAN Journal. 3, p. 42-46

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  41. Pharmacotherapy of schizophrenia spectrum disorders.

    Lambert, M., Moritz, S. & Naber, D., 2004, Schizophrenia Psychiatry Textbook. Naber, D. & Lambert, M. (eds.). Georg Thieme Verlag KG, p. 69-104

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  42. Psychopharmacological and psychosocial Treatment guidelines of acute psychotic episodes in schizophrenia.

    Lambert, M. & Naber, D., 2004, In: Hospital Pharmacy Europe. 14, p. 28-36

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  43. Schneiderian first rank symptoms predict poor outcome within first episode manic psychosis.

    Conus, P., Abdel-Baki, A., Harrigan, S., Lambert, M. & McGorry, P. D., 2004, In: J AFFECT DISORDERS. 81, 3, p. 259-268 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease]

    Naber, D., Lambert, M. & Karow, A., 2004, In: PSYCHIAT PRAX. 31, 2, p. 230-232 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. [The initial dysphoric reaction (IDR) to the first dose of neuroleptics]

    Schimmelmann, B. G., Schacht, M., Perro, C. & Lambert, M., 2004, In: NERVENARZT. 75, 1, p. 36-43 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Therapie akuter Psychosen mit atypischen Neuroleptika.

    Naber, D., Lambert, M. & Rädler, T., 2004, Psychotic Disorders. Falkei, P. & Pajonk, F-G. (eds.). Georg Thieme Verlag KG, p. 37-44

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  47. Treatment philosophy as a basis for integrative therapy for patients with schizophrenia.

    Krausz, M. & Lambert, M., 2004, Schizophrenia Psychiatry Textbook. Naber, D. & Lambert, M. (eds.). Georg Thieme Verlag KG, p. 175-181

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  48. 2003

  49. Amisulpride: a safe and effective option for the long-term treatment of patients with schizophrenia.

    Naber, D. & Lambert, M., 2003, In: INT J PSYCHIAT CLIN. 7, p. 167-175

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  50. Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.

    Haasen, C., Lambert, M., Yagdiran, O., Karow, A., Krausz, M. & Naber, D., 2003, In: INT CLIN PSYCHOPHARM. 18, 2, p. 113-115 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. High dose of Olanzapine in acute agitated schizophrenic patients.

    Lambert, M., 2003, In: Neurology and Psychiatry. 6, p. 25-26

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Neurokognition unter konventionellen und atypischen Neuroleptika: eine methodenkritische Übersicht.

    Moritz, S., Karow, A., Lambert, M. & Naber, D., 2003, Kognition und Schizophrenie - Biopsychosoziale Konzepte. Laser, M. & Goldbeck, F. (eds.). Lengerich: Pabst, p. 32-45

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  53. Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.

    Lambert, M., Holzbach, R., Moritz, S., Postel, N., Krausz, M. & Naber, D., 2003, In: INT CLIN PSYCHOPHARM. 18, 5, p. 251-260 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Pharmacotherapy of first-episode psychosis.

    Lambert, M., Conus, P., Lambert, T. & McGorry, P. D., 2003, In: EXPERT OPIN PHARMACO. 4, 5, p. 717-750 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...4 5 6 7 8 9 10 Next